ORIGINAL ARTICLEThe Personalized Acne TreatmentTool -Recommendations to facilitate apatient-centered approach to acnemanagement from the PersonalizingAcne:Consensus of ExpertsAlison M.Layton,MB ChB,b Andrew Alexis,MD,MPH,Hilary Baldwin,MD,d.e Vincenzo Bettoli,MD,James Del Rosso,DO,Thomas Dirschka,MD,Brigitte Dreno,MD,PhD,i Linda Stein Gold,MD,Julie Harper,MD,Joo Yeon Ko,MD,PhD,Khaled Al Nuaimi,MD,"Hazel H.Oon,MD,Murlidhar Rajagopalan,MD,MBBS,P Marco Rocha,MD,PhD,4 Jo-Ann See,MBBS,"Jonathan Weiss,MD,and Jerry Tan,MDuBackground:Acne,a commonly treated skin disease,requires patient-centered management due to itsvarying presentations,chronicity,and impact on health-related quality of life.Despite this,evidence-basedclinical guidelines focus primarily on clinical severity of facial acne,omitting important patient-anddisease-related factors,including ongoing management.Objectives:To generate recommendations to support patient-centered acne management,whichincorporate priority and prognostic factors beyond conventional clinical severity,traditionally defined bygrading the appearance and extent of visible lesions.Metbods:The Personalizing Acne:Consensus of Experts consisted of 17 dermatologists who used amodified Delphi approach to reach consensus on statements regarding patient-and treatment-relatedfactors pertaining to patient-centered acne management.Consensus was defined as =75%voting "agree"or“strongly agree."Results:Recommendations based on factors such as acne sequelae,location of acne,high burden ofdisease,and individual patient features were generated and incorporated into the Personalized AcneTreatment Tool.From the Skin Research Centre,York University,York,UK;Clinical Research Inc,Windsor,Ontario,Canada;and Depart-Harrogate and District NHS Foundation Trust,Harrogate,UK;ment of Medicine,University of Westem Ontario,Windsor,Weill Comell Medicine,New York,New York;Robert WoodOntario,Canada."Johnson Medical Center,New Brunswick,New Jersey TheFunding sources:Panel members were invited by Galderma,whoAcne Treatment and Research Center,Brooklyn,New York;funded the planning and delivery of this project.MedicalDermatology Unit-Teaching Hospital,Azienda Ospedaliera,writing services,provided by Ogilvy Health UK,were funded byUniversity of Ferrara,Ferrara,Italy;Advanced Dermatology andGaldemma.Cosmetic Surgery,Maitland,Florida9;JDR DermatologyIRB approval status:Not applicable.Research,Las Vegas,Nevada";Centroderm Clinic,WuppertalAccepted for publication March 20,2023.Germany;University Nantes,Insemm,INCIT,Nantes,France;Correspondence to:Alison M.Layton,MB ChB,Harrogate andHenry Ford Health System,Detroit Michigan;DermatologyDistrict NHS Foundation Trust,Harrogate District Hospital,and Skin Care Center of Bimmingham,Birmingham,AlabamaLancaster Park Rd,Harrogate,North Yorkshire,HG2 7SX,UK.Department of Dermatology,Hanyang University College ofE-mail:laytona@btintemet.comMedicine,Seoul,Republic of Korea";Faculty of Medicine2666-3287Sharjah University,Sharj
更新解读-65c0860642-pdf-1.webp)
